Freedom of Information responses from the MHRA - week commencing 22 February 2021
Medicines and Healthcare products Regulatory Agency (MHRA) responses to freedom of information (FOI) requests for week commencing 22 February 2021
- From:
- Medicines and Healthcare products Regulatory Agency
- Published
- 24 March 2021
Documents
Paper part 1 (FOI-21-031)
PDF, 296 KB, 34 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 2 (FOI-21-031)
PDF, 987 KB, 123 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Freedom of Information request about adverse drug reactions (ADR) to COVID-19 vaccines (FOI-21-099)
MS Excel Spreadsheet, 26.1 KB
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 1 (FOI-21-106)
PDF, 4.13 MB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 2 (FOI-21-106)
PDF, 4.2 MB, 25 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 3 (FOI-21-106)
PDF, 5.62 MB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 4 (FOI-21-106)
PDF, 7.27 MB, 34 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 5 (FOI-21-106)
PDF, 4.9 MB, 31 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 7 (FOI-21-106)
PDF, 4.97 MB, 46 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 8 (FOI-21-106)
PDF, 5.61 MB, 51 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 9 (FOI-21-106)
PDF, 4.97 MB, 37 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 10 (FOI-21-106)
PDF, 11.1 MB, 53 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 11 (FOI-21-106)
PDF, 5.93 MB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 12 (FOI-21-106)
PDF, 6.8 MB, 29 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 13 (FOI-21-106)
PDF, 6.12 MB, 30 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 14 (FOI-21-106)
PDF, 4.88 MB, 34 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 15 (FOI-21-106)
PDF, 7.43 MB, 37 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 16 (FOI-21-106)
PDF, 5.49 MB, 39 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 17 (FOI-21-106)
PDF, 6.3 MB, 30 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 1 (FOI-21-132)
PDF, 42 KB, 25 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 2 (FOI-21-132)
PDF, 56.6 KB, 32 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 3 (FOI-21-132)
PDF, 117 KB, 2 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 4 (FOI-21-132)
PDF, 110 KB, 49 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 5 (FOI-21-132)
PDF, 56.6 KB, 32 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 6 (FOI-21-132)
PDF, 63.5 KB, 33 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 7 (FOI-21-132)
PDF, 46.9 KB, 28 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 8 (FOI-21-132)
PDF, 105 KB, 49 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 9 (FOI-21-132)
PDF, 72.3 KB, 38 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 10 (FOI-21-132)
PDF, 51.8 KB, 29 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Paper part 11 (FOI-21-132)
PDF, 70.3 KB, 37 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
Details
See the MHRA FOI disclosure log.
See all FOI responses from the MHRA for 2021.